Related Experiment Video
Updated: Jun 2, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Nicorandil-induced leg ulceration without mucosal involvement.
1Department of Dermatology, York Hospitals NHS Trust, York, UK. jasmina@doctors.org.uk
This study presents a rare case of leg ulceration caused by nicorandil, a medication typically associated with mucosal ulcers. Healing occurred rapidly after discontinuing the drug, highlighting a unique adverse effect.
Area of Science:
- Pharmacology
- Dermatology
- Vascular Medicine
Background:
- Nicorandil is a medication used for angina.
- Nicorandil-induced ulcers commonly affect mucosal surfaces.
- Cutaneous ulcers are rare and often occur with mucosal involvement.
Observation:
- A patient developed a leg ulcer.
- The ulcer did not heal with standard compression therapy.
- Nicorandil was identified as the likely cause.
Findings:
- Discontinuation of nicorandil led to rapid improvement and healing of the leg ulcer.
- This case represents the first reported instance of nicorandil-induced leg ulceration without concurrent mucosal ulcers.
Implications:
- Clinicians should consider nicorandil as a potential cause of cutaneous leg ulcers, even in the absence of mucosal lesions.
- This finding expands the known spectrum of nicorandil adverse effects.
- Further investigation into the mechanisms of nicorandil-induced cutaneous ulceration is warranted.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Diabetic Foot Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Complications